Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
Jonasch E, Wood CG, Matin SF, Tu SM, Pagliaro LC, Corn PG, Aparicio A, Tamboli P, Millikan RE, Wang X, Araujo JC, Arap W, Tannir N.
Jonasch E, et al. Among authors: araujo jc.
J Clin Oncol. 2009 Sep 1;27(25):4076-81. doi: 10.1200/JCO.2008.21.3660. Epub 2009 Jul 27.
J Clin Oncol. 2009.
PMID: 19636008
Free PMC article.
Clinical Trial.